Key Sessions
Kristy Wood
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
Intellia Therapeutics
Ying Cai
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Ultragenyx Pharmaceutical
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
8:50am - 9:00am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
- Christopher Bravery, Ph.D. - Consulting Regulatory Scientist, Advbiols
9:00am - 9:30am
Accelerate Manufacturability and Personalize Therapies with Confidential Collaboration
- Kat Kozyrytska - Founder, Cell Therapy Manufacturability Program
9:30am - 10:00am
Redosable DNA Delivery Systems Designed by Machine Learning
- Shashi Murthy - CTO and Co-Founder, Nanite Inc.
10:00am - 10:30am
Efficient and Liver-Detargeted In Vivo Multiplex Gene Editing of Human Hematopoietic Stem and Progenitor Cells
- Pauline Schmit - Senior Scientist, nChroma Bio
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
11:30am - 12:00pm
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
- Kristy Wood - SVP, Technical Operations, Intellia Therapeutics
12:00pm - 12:30pm
Expanding Gene Editing Beyond The Liver
- Devyn Smith - CEO, Arbor Biotechnologies
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
- Mark Farmery - Chief Development Officer, Anocca AB
2:15pm - 2:45pm
Scientific Track Presentation
2:45pm - 3:15pm
Prime Editor Lipid Nanoparticles: From Development to Scalable Manufacturing
- Weiyi Li - Senior Manager, LNP Formulation, Prime Medicine
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
4:30pm - 5:30pm
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
- Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
- D.J. Harkins - Director, External Manufacturing and Supply, Takeda
- Maura Hobson - Executive Director, External Manufacturing, Sana Biotechnology
- Matthew Provencal - Executive Director Gene Therapy BDS Manufacturing, Sarepta
- Khandan Baradaran - Consulting Leader & Strategic Advisor, PLG North America/Halloran
Filter
Streams
Clear